Burning Rock Announces an Exclusive in-Licensing of a Risk Stratification Test for Early Stage Lung-Cancer Patients from Oncocyte in China
December 15, 2020 01:33 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that it entered into an exclusive licensing agreement...
Burning Rock Announces Pricing of Upsized Registered Secondary Public Offering of American Depositary Shares
December 04, 2020 06:34 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock Announces Proposed Registered Secondary Public Offering of American Depositary Shares
December 01, 2020 18:47 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock Reports Third Quarter 2020 Financial Results
November 20, 2020 06:00 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock Announces In-Licensing of Myriad myChoice® Tumor Testing in China
November 15, 2020 20:00 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 15, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that it entered into a development and...
Burning Rock to Present Validation Data of Magnis BR at the AMP Annual Meeting
October 29, 2020 23:21 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that analytical validation data of its fully-automated...
Burning Rock to Present Data on Its Early Detection ELSA-seq at ESMO Asia Virtual Congress 2020
October 20, 2020 21:30 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that new data for its early detection ELSA-seq test...
Burning Rock Announces Preliminary Third Quarter 2020 Results and Schedules Earnings Release on November 20, 2020
October 20, 2020 21:30 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock to Participate in Morgan Stanley 2020 Healthcare Conference
September 03, 2020 02:09 ET
|
Burning Rock Biotech Limited
SHANGHAI, China, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR) today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare...
Burning Rock Reports Second Quarter 2020 Financial Results
August 11, 2020 00:38 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...